The first hemophilia B patient at the Loma Linda University Health Hemophilia Treatment Center to receive Hympavzi is a ...
Hemophilia may impose some limitations, but it doesn't stop columnist G Shellye Horowitz from finding ways to fly through the ...
Pfizer said it will discontinue gene therapy Beqvez (fidanacogene elaparvovec-dzkt), an approved hemophilia B treatment.
Columnist Jennifer Lynne assesses the effects of Pfizer's decision to halt production of its hemophilia B gene therapy, Beqvez.
It's been several months since his sons have experienced complications of hemophilia, and columnist Joe MacDonald is grateful but anxious.
Every person with hemophilia is unique, especially with a complication like an inhibitor, columnist Cazandra Campos-MacDonald writes.
The Loma Linda University Health (LLUH) Hemophilia Treatment Center has become the first clinic in California offering Hympavzi (marstacimab) for people with hemophilia B. “For the first time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results